Viewing Study NCT06764251


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-01-01 @ 4:54 PM
Study NCT ID: NCT06764251
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-08
First Post: 2024-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma
Sponsor: Liaoning Cancer Hospital & Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module